Rex Hematology Oncology Associates-Cary

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Childhood cancers2 trials
• Obesity1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting4 trials
• Completed1 trial

Lead sponsor

• SWOG Cancer Research Network3 trials
• Alliance for Clinical Trials in Oncology1 trial
• NRG Oncology1 trial

Running trials

• Active, not recruiting

  Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

  NCT05633602· Phase 3· SWOG Cancer Research Network· Source

• Active, not recruiting

  Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial)

  NCT04268550· Phase 2· SWOG Cancer Research Network· Source

• Active, not recruiting

  Breast Cancer WEight Loss Study (BWEL Study)

  NCT02750826· Phase 3· Alliance for Clinical Trials in Oncology· Source

• Active, not recruiting

  Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  NCT02488967· Phase 3· NRG Oncology· Source

Closed trials

• Completed

  Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

  NCT03845296· Phase 2· SWOG Cancer Research Network· Source